Renal replacement therapy in patients with chronic liver disease

Seminars in Dialysis

Volumn 18, Issue 3, 2005, Pages 212-216

  Howard, Clancy S ^a   Teitelbaum, Isaac ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNITOL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BLEEDING; BLOOD CLOTTING DISORDER; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CREATININE CLEARANCE; DIALYSATE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEPARINIZATION; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION;

CHRONIC DISEASE; CREATININE; ETHICS, CLINICAL; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER FAILURE; RENAL DIALYSIS;

EID: 20544434316     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18315.x     Document Type: Review

References (46)

1. Arias E, Anderson RN, Hsiang-Ching K, Murphy SL, Kochanek KD: Deaths: final data for 2001. In: National Vital Statistics Reports, vol. 52, no. 3. Hyattsville, MD: National Center for Health Statistics, 2003:1-116
2. Schrier RW: Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med 319:1127-1134, 1988
3. Hampel H, Bynum GD, Zamora E, El-Serag HB: Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 96:2206-2210, 2001
4. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M, Claria J, Rimola A, Arroyo V, et al.: Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105:229-236, 1993
5. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC: Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 119:1489-1497, 2001
6. Bataller R, Sort P, Gines P, Arroyo V: Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int Suppl 66:S47-S53, 1998
7. Becker T, Nyibata M, Lueck R, Bektas H, Demirci G, Lehner F, Tusch G, Strassburg C, Schwarz A, Klempnauer J, Nashan B: Results of combined and sequential liver-kidney transplantation. Liver Transpl 9:1067-1078, 2003
8. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931-940, 2003
9. Gaspari F, Perico N, Remuzzi G: Measurement of glomerular filtration rate. Kidney Int Suppl 63:S151-S154, 1997
10. Toto RD: Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr Opin Nephrol Hypertens 4:505-509; discussion 503-504, 1995
11. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38:167-184, 1990
12. Sherman DS, Fish DN, Teitelbaum I: Assessing renal function in cirrhotic patients. Problems and pitfalls. Am J Kidney Dis 41:269-278, 2003
13. Cocchetto DM, Tschanz C, Bjornsson TD: Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit 5:161-168, 1983
14. Sansoe G, Ferrari A, Castellana CN, Bonardi L, Villa E, Manenti F: Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis. Clin Sci (Lond) 102:91-98, 2002
15. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, Alberino F, Gatta A: Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 154:201-205, 1994
16. Daugherty NA, Hammond KB, Osberg IM: Bilirubin interference with the kinetic Jaffe method for serum creatinine. Clin Chem 24:392-393, 1978
17. Mullane JF, Gliedman ML: Development of renal impairment in Laennec's cirrhosis. Ann Surg 174:892-901, 1971
18. Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L: Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 311:81-89, 2001
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
20. Skluzacek PA, Szewc RG, Nolan CR 3rd, Riley DJ, Lee S, Pergola PE: Prediction of GFR in liver transplant candidates. Am J Kidney Dis 42:1169-1176, 2003
21. Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A, Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 20:97-102, 2000
22. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, Padrini R, Palatini P: Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850-858, 2002
23. Woitas RP, Stoffel-Wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr HU, Spengler U, Bidlingmaier F, Sauerbruch T: Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 46:712-715, 2000
24. Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 16:224-235, 1990
25. Moreau R, Hadengue A, Soupison T, Mamzer MF, Kirstetter P, Saraux JL, Assous M, Roche-Sicot J, Sicot C: Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. Liver 13:20-24, 1993
26. Kiley JE, Pender JC, Welch HF, Welch CS: Ammonia intoxication treated by hemodialysis. N Engl J Med 259:1156-1161, 1958
27. Cordoba J, Blei AT, Mujais S: Determinants of ammonia clearance by hemodialysis. Artif Organs 20:800-803, 1996
28. Matsubara S, Okabe K, Ouchi K, Miyazaki Y, Yajima Y, Suzuki H, Otsuki M, Matsuno S: Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 18:1331-1338, 1990
29. Opolon P, Lavallard MC, Huguet C, Bidallier M, Granger A, Gallot D, Bloch P: Hemodialysis versus cross hemodialysis in experimental hepatic coma. Surg Gynecol Obstet 142:845-853, 1976
30. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F: Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 19:787-793, 1978
31. Wilkinson SP, Weston MJ, Parsons V, Williams R: Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8:287-292, 1977
32. Brown RS Jr, Lombardero M, Lake JR: Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 62:1788-1793, 1996
33. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS: Impact of pretransplant renal function on survival after liver transplantation. Transplantation 59:361-365, 1995
34. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB: Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation 71:1424-1428, 2001
35. Chin-Dusting JP, Rasaratnam B, Jennings GL, Dudley FJ: Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med 127:985-988, 1997
36. Martin PY, Gines P, Schrier RW: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339:533-541, 1998
37. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151-1157, 1988
38. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 123:35-37, 1995
39. Davenport A, Will EJ, Davison AM: Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 41:S245-S251, 1993
40. Winney RJ, Kean DM, Best JJ, Smith MA: Changes in brain water with haemodialysis. Lancet 2:1107-1108, 1986
41. Donovan JP, Schafer DF, Shaw BW Jr, Sorrell MF: Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 351:719-721, 1998
42. Marcus RG, Messana J, Swartz R: Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 93:35-40, 1992
43. De Vecchi AF, Colucci P, Salerno F, Scalamogna A, Ponticelli C: Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure. Am J Kidney Dis 40:161-168, 2002
44. Davenport A: Continuous renal replacement therapy for liver disease. Hemodial Int 7:348-352, 2003
45. Davenport A, Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21:328-338, 1993
46. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, Losowsky MS: Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 12:439-444, 1989